Skip to main content
. 2021 Apr 9;10(4):411. doi: 10.3390/antibiotics10040411

Table 3.

Neonates with a low risk of early-onset sepsis and antibiotic treatments at baseline and in the intervention period.

Variables Baseline
(n = 26)
Intervention
(n = 34)
p
Male gender, n (%) 12 (46) 18 (53) 0.79
Gestational age, weeks, median (IQR) 31 (29–32) 30 (29–31) 0.04
Birth weight, g, median (IQR) 1320 (1076–1456) 1220 (990–1445) 0.32
Apgar score at the 5th min, median (IQR) 9 (7–10) 8 (7–9) 0.05
CRIB score, median (IQR) 1 (0–1) 1 (0–4) 0.60
Twins, n (%) 4 (15) 5 (15) 0.77
Maternal fever in labor (> 38 °C), n (%) 0 (0) 1 (3) 0.89
IAP, n (%)
No
Adequate
Inadequate

25 (96)
0 (0)
1 (4)

27 (79)
6 (18)
1 (3)


0.04
Prenatal steroids, n (%) 22 (85) 31 (91) 0.43
Median length of stay, days (IQR) 47 (38–57) 46 (42–57) 0.99
First antibiotic treatment
Total, n (%)
48-h rule-out course, n (%) §
Median duration, hours (IQR) §

13 (50)
0 (0)
144 (96–168)

16 (48)
14 (88)
72 (48–72)

0.97
<0.01
<0.01
Days of therapy
Total
Median (IQR)

233
2 (0–15)

190
0 (0–6)

<0.01
<0.01
Days of therapy/1000 patient-days 194 113 <0.01

CRIB, clinical risk index for babies. IAP, intrapartum antibiotic prophylaxis. IQR, interquartile range. Indications of intrapartum antibiotic prophylaxis are: maternal group B streptococcus colonization, preterm birth, group B streptococcus bacteriuria identified during the current pregnancy, previous infant with group B streptococcus infection, membrane rupture ≥ 18 h, maternal temperature ≥ 38 °C during labor. § percent rates and median duration were calculated only on neonates who were given antibiotics.